Summary: Effects of intracerbroventricularly (ICV) administered octreotide on gonadotrophic cells (FSH and LH) of adult Wistar female rats were examined by immunocytochemical and morphometric methods. The animals received ICV three 1.0 mg doses of octreotide dissolved in 10 mL saline every second day. The controls were treated with equivalent volume of physiological saline by the same schedule. FSH-and LH-producing cells were examined using peroxidase-antiperoxidase immunocytochemical procedure. Morphometric and stereologic examinations were performed to evaluate changes in the number, volume and volume densities of gonadotrophic cells. In females treated with octreotide, the gonadotrophic cells were smaller and often pycnotic, while the number of FSH-and LH-immunopositive cells per unit area (mm 2 ) was significantly reduced. Octreotide also induced a significant reduction of the FSH-and LH-immunoreactive cells volume, as well as of their volume densities. On the basis of these results it can be concluded that octeotride, centrally administered to adult female rats provokes changes in immunocytochemical and morphometric features of both types of gonadotrophic cells.
Introduction
Somatostatin or somatotropin release inhibiting hormone (SRIH) was originally detected by Krulich et al. (1) during the studies of the distribution of growth hormone-releasing factor in rat hypothalamus. In 1973, it was characterized by Brazeau et al. (2) and since then attracted much attention because of its wide variety of biological functions in nervous and other tissues. At the periphery, SRIH is a modulator of endocrine and exocrine functions and regulates differentiation and proliferation of normal and tumour cells (3'6) . Within the nervous system, SRIH acts as a neuromodulator with physiological effects on neuroendocrine, motor and cognitive functions (3, 7, 8) . Because of its ability to inhibit many functions of various organs, its therapeutic value in clinical conditions involving the hyperfunction of these organs, was expected. There are two important native bioactive somatostatins: a tetradecapeptide ' somatostatin 14 and an amino-terminal-exteded form somatostatin 28 (SRIH-28). Both of them have a short duration of action (a half-life in the circulation of less than three minutes) which made their clinical use difficult. Thus, octreotide, a synthetic somatostatin analogue consisting of 8 amino acids, was introduced for clinical use. It was shown to inhibit the release of growth hormone (GH), glucagon and insulin in monkeys 45, 11, and 1.3 times more powerfully, respectively, than SRIH-14. Furtheremore, its elimination half-life after subcutaneous administration is two hours (9) .
In the pituitary gland, SRIH dramatically inhibits GH secretion and also blocks the release of other adenohypophyseal hormones such as thyrotrophin (TSH; 2, 10) prolactin (PRL), and in some cases, adrenocorticotropin (ACTH) (11, 12) . However, the effects of SRIHs on gonadotrophin release are still controversial. Several authors reported that SRIH does not affect gonadotrophin secretion (3, 13, 14) . On the other hand, some others found that somatostatin induced reduction of gonadotrophin-producing tumours (15) and their secretion (16) . This prompted us to examine the effects of ICV administered octreotide on immunocytochemical and morphometric properities of gonadotrophic cells in female rats.
Material and Methods

Animals
Adult virgin Wistar female rats maintained at 22 ± 2 °C with a 12/12 h light/dark cycle and free access to water and food, were used.
Surgical procedures were performed under ether anaesthesia. A headset was implanted into the rats and used for intracerebroventricular (ICV) injections. A minimum recovery time of five days was allowed before the experiments. The headset consisted of Silastic-sealed 20-gauge cannula (17) , implanted into the lateral cerebral ventricle, 1.0 mm posterior and 1.5 mm lateral to the bregma and 3 mm below the cortical surface. A small stainless cerebroventricular steel cannula and a screw were cemented in the skull with dental acrylic resin (Stigmall; ICN Galenika).
Treatment protocol
After recovery from the surgery, the rats were divided into two groups each consisting of five animals. Females of the first group received ICV three 1.0 mg doses of octreotide (Sandoz, Switz.) dissolved in 10 mL saline every second day. The second group serving as a control received the equivalent volume of physiological saline by the same schedule. All animals were killed by decapitation under deep ether anaesthesia five days after the last injection.
Immunocytochemistry
The pituitaries were excised, fixed in Bouin's solution, dehydrated and embedded in paraffin wax. Pituitary sections (5 mm thick) were immunocytochemically stained. For immunocytochemistry, series of seven sections of the pituitary cut through three tissue levels (dorsal, middle and ventral portion) of the pars distalis were used. The pituitary gonadotrophs were localized by the peroxidase-antiperoxidase (PAP) method. Non-specific background staining was reduced by incubation with non-immune porcine serum (1:10; 45 min). Anti-rat bLH serum (diluted with PBS 1:500) and anti-rat bFSH (diluted with PBS 1:300) kindly provided by Dr. A.F. Parlow, NIH, Bethesda, MD, USA, served as primary antibodies (45 min, ambient temperature). Subsequently, the sections were treated with secondary antibody (1:200 swine-anti-rabbit IgG; 45 min; a product of DAKO A/S, Glostrup, Denmark) and rabbit-antiperoxidase serum (1:100; 45 min; a products of DAKO A/S, Glostrup, Denmark). The antigen-antibody complex was visualized by incubating the sections with chromogen substrate, 0.05% 3,3-diaminobenzidine (DAB; Serva, Heidelberg, Germany) and 0.03% H 2 O 2 . The incubated sections were counterstained with haematoxylin. Control sections were incubated with normal porcine serum without primary antisera.
Morphometry
Immunocytochemically stained sections of pituitaries cut through three tissue levels of the pars distalis were used for morphometric examinations of antirat bFSH and anti-rat bLH reactive cells with visible nuclei. The cell volume of gonadotrophic cells (Vc) and their volume densities (VV) were estimated under the light microscope at 1000 Vv magnification on 5 mm thick sections, using the M 42 multipurpose test system (18) . The volumes of FSH-and LH-positive cells were expressed in mm 3 and their volume densities as percentages of total pituitary cells in mm 3 . At the same time, the number of immunoreactive cells per unit area (mm 3 ) in each section was analyzed.
Results
Gonadotrophic cells (FSH and LH) of control female rats were strongly immunostained, present throughout pituitary pars distalis, occasionally alone or in clusters and often in close contact with blood capillaries (Figs. 1a, b) . They were large, polygonal, oval or polyhedral in shape, with prominent, often eccentrically located nuclei. In the group ICV treated with octreotide, gonadotrophic cells were smaller comparing to the controls and often pycnotic (Figs. 1b, c) .
In pituitaries of octreotide-treated female rats, the number of FSH-and LH-immunoreactive cells per unit area (mm 2 ) was decreased by 21.4% and 17.2%, respectively, and the difference in comparison with the control was statistically significant (p<0.005) ( Figure  2a) . Stereological analysis showed that octreotide treatment resulted in a significant volume decrease in both types of gonadotrophic cells (Figure 2b) . The volume of immunopositive FSH cells was reduced by 15.6% (p<0.01), while the immunolabelled LH cell volume was decreased by 20.6% (p<0.005). In octreotide-treated females the percentage of FSHand LH-positive cells per volume unit (mm 3 ) of total pituitary gland tissue, i.e. the volume density, was significantly reduced and the extent of this reduction was about equal in both types of gonadotrophic cells (Figure 2c) . Namely, volume density of FSH-immunopositive cells was decreased by 30.6% (p<0.001) and that of LH-reactive cells by 30.1%.
Discussion
The pituitary gland is a major target for the physiological actions of somatostatins. Although some ) of immunoreactive FSH and LH cells expressed in percentages (%) of total adenohypophyseal cells in mm 3 in control (C) and octreotide-treated rats. All values are presented as means ± SD. *p<0.01, **p<0.005, ***p<0.001. (3, 13, 14) , our results clearly demonstrate that centrally used somatostatin analogue octreotide acted inhibitory on immunocytochemical and morphometric characteristics of both types of gonadotrophic cells. FSH-and LH-immunoreactive cells were often pycnotic after three bolus ICV injections of octreotide, what is a clear sign of its inhibitory influence. The number of gonadotrophic cells per unit area of pituitary pars distalis was lower in octreotide-treated females rats than in the controls that received physiological saline by the same route. Furthermore, stereological analysis showed a significant decrease in volume and volume densities of FSH-and LH cells after octreotide treatment.
The inhibitory action of somatostatin was also detected under in vitro conditions. It suppressed LH secretion in cultured human foetal cells (19) and significantly inhibited LH but not FSH release in the presence of luteinizing hormone releasing hormone (LHRH) in the culture of rat pituitary cells (20) . It should also be mentioned, that octreotide efficiently lowered high LH levels in women with polycystic ovary syndrome (PCOS; 21). We have previously demonstrated in vivo inhibition of pituitary gonadotrophs by somatostatin. Intracerebroventricularly administered SRIH-14 and -28 acted inhibitory on pituitary FSH and LH cells of adult rat females, as judged by morphometric parameters (22) . Furthermore, both these somatostatins, ICV administered to male rats, not only induced a decrease in LH cells size, but also reduced LH serum levels (23) .
The biological effects of somatostatin are mediated through its five distinct receptor subtypes (SSTR 1 '5) . The presence of all five SSTR's mRNA in every type of hormone-secreting cells (GH, TSH, PRL, LH, FSH and ACTH) of rat pituitary gland was documented by O'Carroll and Krempels (24) . According to these authors the majority of LH cells was colocalized with SSTR-2 mRNA, while FSH cells expressed low but similar amounts of all five SSTR mRNAs. In a parallel study, Day et al. (25) detected colocalization of SSTR-2 and -5 mRNAs in FSH-secreting cells, while among these two, SSTR-5 was dominant. Octreotide primarily interacts with SSTR-2 and SSTR-5 and binds with a moderate affinity at SSTR-3 (26) . Therefore, this somatostatin analogue can affect both types of gonadotrophic cells. The ability of octreotide to reduce the size and secretion of gonadotropinomas (15, 16) and to lower pathologically high LH levels in women with PCOS may be of a very important clinical relevance.
In conclusion, our results indicate that ICV administered somatostatin analogue octreotide exerts significant inhibitory effects on the immunocytochemical and morphometric characteristics of both types of gonadotrophs. Kratak sadr`aj: Ispitivani su efekti oktreotida davanog intracerebroventrikularno (ICV) odraslim `enkama pacova na gonadotropne }elije (FSH i LH). @ivotinje su tretirane sa ukupno tri doze od 1 mg oktreotida rastvorenog u 10 mL fiziolo{kog rastvora svakog drugog dana. Kontrole su na isti na~in primile odgovaraju}u zapreminu fiziolo{kog rastvora. FSH i LH }elije su ispitivane imunocitohemijskim postupkom peroksidaza-antiperoksidaza. Da bi se ustanovile promene u broju, zapremini i zapreminskoj gustini gonadotropnih }elija primenjen je morfometrijski kao i stereolo{ki pristup. Kod `enki tretiranih oktreotidom, gonadotropne }elije su bile manje i ~esto piknoti~ne. Broj imunopozitivnih FSH i LH }elija po jedinici povr{ine (mm 2 ) je bio statisti~ki zna~ajno smanjen. Oktreotid je, takodje, izazvao zna~ajno smanjenje zapremine FSH i LH imunoreaktivnih }elija, kao i njihove zapreminske gustine. Na osnovu ovih rezultata, mo`e se zaklju~iti da je oktreotid, dat ICV odraslim `enkama pacova doveo do promena imunocitohemijskih i morfometrijskih osobina oba ispitivana tipa gonadotropnih }elija.
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